4.5 Article

Infusion of ex-vivo expanded human TCR-+ double-negative regulatory T cells delays onset of xenogeneic graft-versus-host disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medical Laboratory Technology

Antigen-specific regulatory T cells: are police CARs the answer?

Nicholas A. J. Dawson et al.

TRANSLATIONAL RESEARCH (2017)

Review Immunology

Recent Developments in Cellular immunotherapy for HSCT-Associated Complications

Monica Reis et al.

FRONTIERS IN IMMUNOLOGY (2016)

Article Cell Biology

Hurdles in therapy with regulatory T cells

Piotr Trzonkowski et al.

SCIENCE TRANSLATIONAL MEDICINE (2015)

Review Immunology

Human cell-based artificial antigen-presenting cells for cancer immunotherapy

Marcus O. Butler et al.

IMMUNOLOGICAL REVIEWS (2014)

Article Multidisciplinary Sciences

Ex Vivo Expansion of Human CD8+ T Cells Using Autologous CD4+ T Cell Help

Marcus O. Butler et al.

PLOS ONE (2012)

Article Cell Biology

Mouse models of graft-versus-host disease: advances and limitations

Mark A. Schroeder et al.

DISEASE MODELS & MECHANISMS (2011)

Article Immunology

Regulation of antigen-expressing dendritic cells by double negative regulatory T cells

Julia Fang Gao et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2011)

Article Immunology

Implication of the CD47 pathway in autoimmune diabetes

Veronique Dugas et al.

JOURNAL OF AUTOIMMUNITY (2010)

Article Immunology

Donor double-negative Treg promote allogeneic mixed chimerism and tolerance

Kathy M. He et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2007)

Article Immunology

Peptide-activated double-negative T cells can prevent autoimmune type-1 diabetes development

Megan S. Ford et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2007)

Review Biotechnology & Applied Microbiology

B cells move to centre stage: novel opportunities for autoimmune disease treatment

Jeffrey L. Browning

NATURE REVIEWS DRUG DISCOVERY (2006)

Article Immunology

Inhibition of graft-versus-host disease by double-negative regulatory T cells

KJ Young et al.

JOURNAL OF IMMUNOLOGY (2003)